|Audentes Therapeutics Announces Pricing of Public Offering of Common Stock|
BofA Merrill Lynch,
Registration statements relating to these securities have become effective as of
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Safe Harbor Statement
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/audentes-therapeutics-announces-pricing-of-public-offering-of-common-stock-300441484.html
Investors + Media